The Filing Desk

Bausch Health Companies vs Universe Pharmaceuticals

Bausch Health Companies BHC · Universe Pharmaceuticals UPC · Pharmaceuticals

Universe Pharmaceuticals reported revenue of $17.9 billion in fiscal 2025, 1.7 times Bausch Health Companies' $10.3 billion in fiscal 2025. Bausch Health Companies' revenue grew 6.7% in its latest year, and Universe Pharmaceuticals' fell 22.4%. Bausch Health Companies had an operating margin of 17.7%, against -16.3% at Universe Pharmaceuticals. Free cash flow was $1.0 billion at Bausch Health Companies and −$5.3 billion at Universe Pharmaceuticals. Their fiscal years end in different months (December 31 and September 30), so the periods don't line up exactly.

Side by side

Bausch Health CompaniesUniverse Pharmaceuticals
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Sep 30, 2025
Revenue$10.3B$17.9B
Revenue growth6.7%−22.4%
Revenue growth a year, last 5 years5.0%257.2%
Gross margin—35.3%
Operating margin17.7%−16.3%
Net margin1.5%−20.6%
Free cash flow$1.0B−$5.3B
Free cash flow margin9.8%−29.8%
Return on capital4.5%—
Net debt to EBITDA6.5x—
Dividends and buybacks$0M$0M
Change in diluted share count1.9%3,174.9%
Last close$8.56$1.36
P/E at the last close——
Insider trades, last 12 monthsbought $15.6 million, sold $506,730—
Piotroski F-score7 of 8—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Bausch Health CompaniesUniverse Pharmaceuticals
Operating margin
Percent of revenue
Bausch Health CompaniesUniverse Pharmaceuticals
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Bausch Health CompaniesUniverse Pharmaceuticals

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Bausch Health Companies and Universe Pharmaceuticals pages.